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Fatal Community-acquired 
Pneumonia in Children Caused by 
Re-emergent Human Adenovirus 7d 
Associated with Higher Severity of 
Illness and Fatality Rate
Zhiwu Yu1, Zhiwei Zeng2, Jing Zhang2, Yuxian Pan1, Manjun Chen1, Yonghui Guo1, Nan Yu1, 
James Chodosh3, Ning Fu1, Xiaoyan Che1,* & Qiwei Zhang2,3,*
Human adenoviruses (HAdVs) are highly contagious pathogens causing acute respiratory disease (ARD), 
such as community-acquired pneumonia. HAdV-7d, a re-emergent genomic variant, has been recently 
reported in Asia and the United States after a several-decade absence. However, whether HAdV-7d 
is associated with higher severity than other types is currently unclear. In this study, the clinical and 
epidemiological investigation showed that fever, cough, and sore throat were the three most common 
respiratory symptoms of HAdV infections. HAdV-7 caused longer duration of fever, higher morbidity of 
tachypnea/dyspnea, pleural effusion, diarrhea, hepatosplenomegaly, consciousness alteration, as well 
as higher rates of pneumonia, mechanical ventilation and higher fatality rate (28.6%) than other types, 
particularly HAdV-3 and HAdV-2. The genomes of seven HAdV-7d isolates from mild, severe, and fatal 
cases were sequenced and highly similar with each other. Surprisingly, two isolates (2011, 2012) had 100% 
identical genomes with an earlier strain from a fatal ARD outbreak in China (2009), which elucidates the 
virus origin and confirms the unexpected HAdV genomic conservation and stability. Phylogenetic analysis 
indicated that L1 52/55-kDa DNA packaging protein may be associated with the higher severity of illness 
and fatality rate of HAdV-7. Clinicians need to be aware of HAdVs in children with ARD.
Human adenoviruses (HAdVs) are highly contagious pathogens and associated with a broad spectrum of human 
diseases, such as acute respiratory disease (ARD), including bronchopneumonia, community-acquired pneumo-
nia (CAP) and upper respiratory tract infection1–4. The infections in immunocompetent individuals are usually 
mild and self-limiting, but more and more severe and even fatal cases in children and immunocompetent adults 
caused by emergent and re-emergent HAdV types have been reported1,3,5–10.
Of the seven HAdV species, species B (mostly HAdV-3, -7, -14, and -55) and species E (HAdV-4) are highly 
associated with ARD, which account for a high proportion of respiratory diseases both in children and adults 
throughout the world1,2,11–23. HAdV-7 is one of the most important respiratory HAdVs and has been circulating 
both in military and civilian populations. It accounts for nearly 20% of all HAdVs reported to the World Health 
Organization24 and is associated with severe respiratory disease13,25–27.
Recently, more and more ARD outbreaks with severe or even fatal cases caused by HAdV-7 have been reported 
in Asia, especially in China, which has a large and high-density population1,6,11,13,15,16,28–31. The three recent iso-
lates circulating in Southern China (DG01; 2011), Southwestern China (CQ1198; 2010), and Northwestern 
China (0901HZ/ShX; 2009) were identified as a re-emergent genome type 7d (HAdV-7d) after approximately 
20-year absence in China1. In the United States, the recent emergence of HAdV-7d during 2013–2014 caused 
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many hospitalizations and fatal CAP in adult civilians27,32. These emergent or re-emergent HAdV-7d variants 
may have powerful potential to cause more outbreaks, not only in Asia with its dense population centers, but also 
in Americas.
More and more ARD outbreaks and fatal cases caused by HAdVs have aroused increasing public health con-
cern about the emergence and re-emergence of human adenoviruses variants (http://english.caijing.com.cn/2012-
03-13/111741354.html). Vaccines against HAdV-4 and HAdV-7 have been adopted once again for military 
recruits (http://www.baltimoresun.com/health/bs-hs-military-adenovirus-20120312-story.html). Therefore, in 
this study, we investigated the clinical features and molecular epidemiology of HAdVs circulating among pediat-
ric inpatient and outpatient children with ARD during 2010-2012 in Guangzhou, Southern China. Furthermore, 
in order to better understand the association between the disease severities and HAdV types, the comparison of 
clinical and epidemiological features as well as comparative genomic analysis of the seven HAdV-7d isolates was 
also performed.
Results
Respiratory pathogens detected in pediatric patients in Southern China, 2010–2012. From 
January 2010 to December 2012, 1,482 of 1,945 ARD cases of inpatients and outpatients (76.2%) were positive 
for at least one respiratory virus, including 434 (22.31%) cases of RSV, 293 (15.06%) cases of RHV, 261 (13.42%) 
cases of influenza A and B, 163 (8.38%) cases of HPIV, 99 (5.09%) cases of HAdV, 90 (4.63%) cases of HCoV, 79 
(4.06%) cases of HBoV, 63 (3.24%) cases of hMPV (Fig. 1). There were 463 (23.80%) cases with an undetected 
pathogen from the above.
Molecular types of human adenoviruses circulating in Southern China. Seventy-nine specimens 
from the 99 enrolled patients were CPE-positive by cell culture. The predominant circulating types were HAdV-3 
(61; 61.6%) and HAdV-7 (15; 15.2%), followed by HAdV-2 (12; 12.1%) and HAdV-1 (4; 4.1%). Thirty-four cases 
(34.3%) had co-infection with at least one respiratory virus. RSV and HBoV (8, 23.5% each) were the most com-
mon respiratory pathogens in children co-infected with HAdVs. HAdV-14, HAdV-21, HAdV-55 (2; 2% each), 
and HAdV-19 (1; 1%) were identified without co-infections with any viruses (Table 1).
Epidemiology of human adenoviruses in children with ARD. The temporal distribution of 99 cases 
of HAdVs was shown in Fig. 2. In 2010, there were 27 ARD cases caused by HAdV-1, -2, -3, -7, and -14; in 2011, 
there were 41 HAdV-related ARD cases. HAdV-1, -2, -3 and -7 were identified every year, whereas HAdV-14 and 
HAdV-55 emerged in 2010 and 2011, respectively (Fig. 2A). HAdV prevalence peaked in December 2010, March 
2011, and June 2012, respectively (Fig. 2B).
The seasonal distributions of the HAdVs were further analyzed (Table 2). Overall, the prevalence peaked 
in the summer (33; 7.67%). There was no significant statistical difference in the prevalence peaks between the 
summers in 2010–2012 (6.49–9.59%, p = 0.763). However, when looking at the seasonal peaks in each year, 
HAdV-positive rate in the winter of 2010 (10; 14.71%) was significantly higher than the other winters of 2011 and 
2012 (p < 0.001); the prevalence of pediatric ARD associated with HAdVs was significantly higher in 2010 (27; 
6.51%) and 2011 (41; 6.81%) than in 2012 (31; 3.34%).
Figure 1. Respiratory pathogens detected in pediatric ARD patients in Southern China, 2010–2012. 
Human adenovirus (HAdV), influenza virus A and B (Flu A & B), human parainfluenza virus (HPIV) types 1–4, 
respiratory syncytial virus (RSV), respiratory enteroviruses and rhinoviruses (RHV), human metapneumovirus 
(hMPV), human coronaviruses (HCoV) 229E, OC43, NL63 and HKU1, human bocavirus (HBoV) were 
detected from 1,945 ARD cases by real-time fluorescent PCR. The number of positive cases and corresponding 
percent are shown for all the detected pathogens.
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Demographic characteristics of HAdV-positive children with ARD in 2010–2012. Overall, 
the median age with HAdV infection was 33.5 months (0.7 months - 13 years); 89% were under 5 years; the 
male-to-female ratio was 2.19:1. Of the 99 HAdV-positive cases, 69 (69.7%) were hospitalized; 24 (24.2%) chil-
dren without underlying health conditions were admitted to the intensive care unit (Table 3).
Virus HAdV (%) RSV HBoV RHV HPIV hMPV HCoV Flu A
HAdV-3 61 (61.6) 4 6 3 5 2 5 1
HAdV-2 12 (12.1) 0 1 1 1 1 1
HAdV-7 15 (15.2) 3 1 1
HAdV-1 4 (4.1) 1
HAdV-14 2 (2)
HAdV-19 1 (1)
HAdV-21 2 (2)
HAdV-55 2 (2)
Total (%) 99 8 (23.5) 8 (23.5) 5 (14.7) 6 (17.6) 3 (8.8) 6 (17.6) 1 (2.9)
Table 1.  HAdV types and co-infections with other respiratory viruses in children with ARD in Southern 
China, 2010–2012. HAdV, human adenovirus; RSV, respiratory syncytial virus; ARD, acute respiratory disease; 
HBoV, human bocavirus; RHV, respiratory enteroviruses and rhinoviruses; hMPV, human metapneumovirus; 
HPIV, human parainfluenza viruses (type 2 and 3); HCoV, human coronaviruses (OC43, NL63); Flu A, 
influenza A.
Figure 2. The temporal and type distribution of HAdVs associated with ARD in Guangzhou, Southern 
China from 2010 to 2012. There were 27 HAdV-positive cases in 2010, 41 cases in 2011 and 31 cases in 2012 
(A). The monthly ARD cases associated with specific HAdV types were also indicated (B).
Year
Spring  
(March–May)
Summer  
(June–August)
Autumn  
(September–November)
Winter  
(December–February) All p value
2010 1/14 (7.14%) 5/77 (6.49%) 11/256 (4.3%) 10/68 (14.71%) 27/415 (6.51%) 0.026*
2011 18/214 (8.41%) 7/73 (9.59%) 6/111 (5.41%) 10/204 (4.9%) 41/602 (6.81%) 0.352
2012 9/281 (3.2%) 21/280 (7.5%) 1/125 (0.8%) 0/242 31/928 (3.34%) < 0.001*
Total 28/509 (5.5%) 33/430 (7.67%) 18/492 (3.66%) 20/514 (3.89%) 99/1945 (5.09%) 0.021*
p value 0.028* 0.763 0.125 < 0.001* 0.004*
Table 2.  The seasonal distribution of HAdV-positive cases in children with ARD during 2010–2012. The 
percent are the ratios of HAdV-positive cases to all ARD cases in the corresponding season. “*” indicates a 
significant difference between seasons or years.
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Comparison of clinical features and laboratory findings of the hospitalized children caused by 
HAdV-7 and other types. Nearly all the hospitalized patients associated with HAdV infections had fever 
(94.1%) (Table 4). The median peak of body temperature was 39.7 °C (range: 37.5–42 °C). The median duration of 
fever was 5.3 days (range: 1–23 days). Besides fever, sore throat (79.4%) and cough (75%) were also the most com-
mon respiratory symptoms of the inpatients. Lower respiratory tract infections were the most common diagnoses 
in the hospitalized patients, including 28 bronchopneumonia (41.2%), 17 pneumonia (25%), and 7 bronchitis 
(10.3%) cases. The median duration of hospitalization was 10.6 days (range: 2–83 days). Two inpatients infected 
by HAdV-3 and five patients infected by HAdV-7 required mechanical ventilation during intensive care. Four 
inpatients infected by HAdV-7 without any co-infection died after treatment; three deaths were associated with 
multiple organ failure, and the other one associated with acute respiratory distress syndrome.
Characteristics All HAdV-1 HAdV-2 HAdV-3 HAdV-7 HAdV-14 HAdV-19 HAdV-21 HAdV-55
No. of children 99 4 12 61 15 2 1 2 2
Hospitalized 69 (69.7%) 2 (50%) 8 (66.7%) 39 (63.9%) 14 (93.3%) 2 (100%) 1 (100%) 1 (50%) 2 (100%)
Age range (m) 0.7–156 12–36 0.7–52.7 3.9–156 5.9–91.6 22.5–26.1 11 12.6–144 11.8–40.2
Median age (m) 33.5 19.9 24.4 38.2 23.2 24.3 11 78.3 26
Gender (M/F) 68/31 3/1 7/5 44/17 9/6 1/1 1/0 1/1 2/0
Intensive care 24 (24.2%) 0 0 13 (21.3%) 8 (53.3%) 1 (50%) 0 1 (50%) 1 (50%)
Table 3.  Demographic characteristics of 99 children with ARD according to HAdV type in Guangzhou, 
Southern China 2010–2012.
Characteristics All (n = 68)
HAdV-7 
(n = 14)
The other types 
(n = 54) p value
Fever 64 (94.1) 14 (100) 50 (92.6) 0.574
Duration days (range)* 5.3 (1–23) 8.6 (3–23) 4.4 (1–21) 0.039
Median peak temperature (range) 39.7 (37.5–42) 39.6 (38.4–40.6) 39.8 (37.5–42) 0.555
Cough 51 (75) 13 (92.8) 38 (70.4) 0.162
Runny nose 21 (30.9) 4 (28.6) 17 (31.5) 1.000
Sore throat 54 (79.4) 12 (85.7) 42 (77.8) 0.717
Expectoration 28 (41.2) 8 (57.1) 20 (37.0) 0.173
Rales 28 (41.2) 8 (57.1) 20 (37.0) 0.173
Wheezing 18 (26.5) 6 (42.8) 12 (22.2) 0.173
Tachypnea/dyspnea* 26 (38.2) 10 (71.4) 16 (29.6) 0.004
Pleural effusion* 10 (14.7) 8 (57.1) 2 (3.7) < 0.001
Cyanosis 5 (7.3) 2 (14.3) 3 (5.6) 0.272
Tonsillitis 33 (48.5) 5 (35.7) 28 (51.8) 0.282
Extrapulmonary manifestations
 Skin rash 8 (11.8) 1 (7.1) 7 (12.9) 1.000
 Conjunctivitis 4 (5.9) 1 (7.1) 3 (5.6) 1.000
 Diarrhea* 12 (17.6) 6 (42.8) 6 (11.1) 0.012
 Vomiting 9 (13.2) 3 (21.4) 6 (11.1) 0.377
 Hepatosplenomegaly* 21 (30.9) 8 (57.1) 13 (24.1) 0.025
 Seizure 8 (11.8) 2 (14.3) 6 (11.1) 0.665
 Consciousness alteration* 5 (7.3) 4 (28.6) 1 (1.8) 0.005
Clinical outcomes
 Upper respiratory tract infection 16 (23.5) 1 (7.1) 15 (27.8) 0.161
 Bronchitis 7 (10.3) 2 (14.3) 5 (9.3) 0.627
 Bronchopneumonia 28 (41.2) 3 (21.4) 25 (46.3) 0.092
 Pneumonia* 17 (25) 8 (57.1) 9 (16.7) 0.004
  Median duration of hospitalized days 
(range) 10.6 (2–83) 18.7 (3–83) 8.5 (2–45) 0.075
 Mechanical ventilation* 7 (10.3) 5 (35.7) 2 (3.7) 0.003
 Death* 4 (5.9) 4 (28.6) 0 0.001
Table 4.  Comparison of clinical characteristics of 68 hospitalized children infected by HAdV-7 and the 
other types. The values indicate the number (%) of corresponding children. “HAdV-7” group are the children 
infected by HAdV-7; “The other type” group are the children infected by adenovirus types 1, 2, 3, 14, 19, 21 and 
55. “*”: a significant difference between groups.
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Fourteen of 15 children infected with HAdV-7 were hospitalized and 8 (53.3%) needed intensive care 
(Table 3). Compared with ARD inpatients caused by the other types, the inpatients infected by HAdV-7 had more 
severe clinical symptoms (Table 4). They had longer duration of fever (8.6 vs. 4.4 days; p = 0.039), the higher mor-
bidity of tachypnea/dyspnea (71.4% vs. 29.6%; p = 0.004), more pleural effusion (57.1% vs. 3.7%; p < 0.001), diar-
rhea (42.8% vs. 11.1%; p = 0.012), hepatosplenomegaly (57.1% vs. 24.1%; p = 0.025), and consciousness alteration 
(28.6% vs. 1.8%; p = 0.005). The clinical outcomes of these inpatients were also more severe than non-HAdV-7 
infected inpatients, including the occurrence of pneumonia (57.1% vs. 16.7%; p = 0.004), mechanical ventilation 
required (35.7% vs. 3.7%; p = 0.003), and significantly higher fatality rate (28.6% vs. none; p = 0.001).
Some laboratory findings from the HAdV-7-positive inpatients were also different from those infected by 
other types (Table 5). HAdV-7-positive inpatients had lower white blood cell count (6.85 vs. 12.95 × 109 cells/L; 
p < 0.001), platelet count (188 vs. 273 × 109 cells/L; p = 0.007), hemoglobin levels (95.08 vs. 108.6 g/L; p = 0.001) 
and serum calcium levels (1.92 vs. 2.24 mmol/L; p < 0.001) than the inpatients infected by other types (Table 5). 
On the contrary, the lactate dehydrogenase levels (940.8 vs. 429.5 IU/L; p = 0.037), the morbidity of hyponatremia 
(36.4% vs. 23.1%; p = 0.022), and the albuminuria rate (45.5% vs. 4.8%; p = 0.003) were found significantly higher 
in the HAdV-7 group than the other group.
Comparative genomic analysis of the seven HAdV-7 isolates associated with severe and mild 
ARD. In order to better understand the association of the genetic characteristics of HAdV-7 and clinical 
manifestations and outcomes between children with severe ARD and mild respiratory disease, seven represent-
ative HAdV-7 isolates, including one from an outpatient (OP) causing mild respiratory disease (OP01_2011), 
three from inpatients (IP; fatal outcome) named IP01_2010, IP02_2011 and IP03_2011, two from severe cases 
(IP04_2011 and IP05_2012) (required intensive care and mechanical ventilation), and one from an IP with com-
paratively mild ARD (IP06_2012) (diagnosed as bronchitis; discharged after 4-day hospitalization), were selected 
to perform next-generation whole-genome sequencing on Ion Torrent PGMTM using 318 v2 chips; it yielded 
6,063,042 reads with an average length of 182 bp, which was obtained with a mean coverage of 2,409x. The assem-
bly in each samples yielded 3 or 4 contigs after PASA analysis. All of these samples have one long contig covering 
above half of the reference genome (N50 > 17 kb). The local coverage rates varied between 91–92%. The num-
bers of gaps identified in each samples were 3–5. These gaps were covered by Sanger sequencing for more than 
three times (84 in total) following PCR amplification. The complete genome sequences of strains OP01_2011, 
IP01_2010, IP02_2011, IP03_2011, IP04_2011, IP05_2012 and IP06_2012 were deposited in the GenBank data-
base under accession nos. KP670857, KP670858, KP670856, KP670855, KP670861, KP670860, and KP670859, 
respectively.
Sequence analysis demonstrated these seven isolates had identical hexon, fiber and penton base genes. The 
further genome pairwise alignments indicated that the genome sequences of the 2 isolates (IP04_2011 and 
IP06_2012) were 100% identical with each other as well as with the previous HAdV-7 strain 0901HZ/ShX/2009, 
which was associated with the fatal pneumonia in an ARD outbreak in the Shaanxi Province of China in 20097,15. 
The genome sequence identities between both isolates and the other five isolates were extremely high (more 
than 99.98%). When compared with strain 0901HZ/ShX/2009, the genomes of both isolates OP01_2011 and 
IP05_2012 contained only one single T insertion in E3 non-coding region and Virus-Associated (VA) RNA II, 
respectively (Table 6). Isolate IP01_2010 contained four nucleotide mutations (G to A) in membrane protein E3 
RID-alpha, which led to four non-synonymous substitutions in this protein. There was only one synonymous 
Laboratory data and no. patients tested All HAdV-7 (n = 14) The other types (n = 54) p value
*WBC, × 109 cells/L, n = 68 11.69 6.85 (1.9–13.7) 12.95 (4–34.84) < 0.001
LYM, × 109 cells/L, n = 68 3.1 2.65 (0.52–4.84) 3.23 (0.47–20.67) 0.477
*Platelets, × 109 cells/L, n = 68 256 188 (36–377) 273 (32.3–595) 0.007
*Hemoglobin, g/L, n = 68 105.8 95.08 (69–115) 108.6 (67–135) 0.001
CRP, mg/L, n = 63 29.03 39.2 (1.05–169) 26.12 (0.16–159) 0.248
AST, IU/L, n = 66 87.8 156.4 (29–629) 69.3 (15–1460) 0.143
ALT, IU/L, n = 64 26.2 28.1 (13–102) 25.7 (9–268) 0.813
*LDH, IU/L, n = 62 528.4 940.8 (258–2454) 429.5 (151–2020) 0.037
Creatinine, μ mol/L, n = 66 43.5 41.14 (29–65) 44.17 (12–104) 0.486
Urea, mmol/L, n = 66 2.99 2.6 (0.7–7.1) 3.1 (0.6–8.4) 0.29
Sodium, mmol/L (range), n = 66 136.8 135.4 (129.1–140.7) 137.1 (130.3–145.2) 0.082
*Hyponatremia, no. (%) patients 20 (30.3%) 8 (36.4%), n = 14 12 (23.1%), n = 52 0.022
*Calcium, mmol/L, n = 63 2.18 1.92 (1.55–2.43) 2.24 (1.86–2.64) < 0.001
*Albuminuria, no. (%) patients, n = 53 7 (13.2%) 5 (45.5%), n = 11 2 (4.8%), n = 42 0.003
Hematuria, no. (%) patients, n = 53 5 (9.4%) 3 (27.3%), n = 11 2 (4.8%), n = 42 0.054
Urinary casts, no. (%) patients, n = 53 3 (5.6%) 2 (18.2%), n = 11 1 (2.4%), n = 42 0.106
Table 5.  Comparison of laboratory findings of 68 hospitalized children with ARD associated with HAdV-7 
and the other types. The values are median (range) of tested number. WBC, white blood cell; LYM, lymphocyte; 
PLT, platelet; Hb, hemoglobin; CRP, C-reactive protein; AST, aspartate aminotransferase; ALT, alanine 
aminotransferase; LDH, lactate dehydrogenase; hyponatremia, serum sodium < 135 mmol/L. “*”: a significant 
difference between groups.
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substitution (C to T) in hexon assembly-associated protein of isolates IP02_2011. Isolate IP03_2011 had one more 
non-synonymous substitution located in 34 kDa protein (G to T).
Genome type determination of the seven HAdV-7 isolates. Although seemingly antiquated when 
compared with genome sequencing, REA profiles are still helpful to compare the unsequenced but previously 
reported genome types and strains1. The genome types of all seven HAdV-7 isolates were determined by com-
paring REA profiles from both in silico (Fig. 3A) and agarose gel electrophoresis (Fig. 3B) with other HAdV-7 
genome types reported earlier1. Isolates OP01_2011, IP01_2010, IP02_2011, and IP05_2012 were chosen as rep-
resentatives for in silico REA (Fig. 3A); IP01_2010 and IP06_2012 were chosen for agarose gel electrophoresis 
REA (Fig. 3B). The REA profiles of HAdV-7 prototype strain Gomen and HAdV-7d strain DG01_2011 were 
chosen as references. According to the genome type denomination of Li, et al.33, all of these seven strains are iden-
tified as HAdV-7d (Fig. 3), evidenced by the REA patterns and identical with the first reported HAdV-7d33–35, as 
well as with the re-emergent HAdV-7d strains DG01_2011 and 0901HZ/ShX/20091,7,15.
Phylogenetic analysis of hexon, fiber, penton base genes, L1 52/55 kDa DNA packaging protein 
gene and the whole genomes. Phylogenetic analysis of the hexon, penton base, and fiber gene of China 
isolates showed no substantial differences from those found in the Japanese, Korean and US isolates (bootstrap 
values less than 80) (Fig. 4A, 4B, 4C). Phylogenetic analysis of fiber gene showed that this gene was highly con-
served in all the HAdV-7 isolates analyzed (Fig. 4C). However, the phylogenetic tree based on L1 52/55 kDa 
DNA packaging protein indicated that the isolates circulating in China, USA, and Argentina were much closer to 
HAdV-16, and distinct from the HAdV-7 prototype Gomen strain (1952) (Fig. 4D). Additionally, phylogenetic 
analysis of 31 available HAdV-7 whole genomes revealed that the seven HAdV-7d isolates represented an unu-
sual clade (bootstrap value: 100) along with the other HAdV-7d strains circulating in China, including 0901/HZ/
ShX/2009, CQ1198_2010, DG01_2011 (Fig. 4E), which was distinct from the HAdV-7d2 USA strains and the proto-
type Gomen strain (Fig. 4A, 4B, 4D). The overall genome sequences of these hyper-virulent isolates are very distinct.
Discussion
CAP is a common and serious infection that afflicts children throughout the world36. It is the world’s most impor-
tant cause of child death37. In the United States, the annual incidence of pneumonia was 15.7 cases per 10,000 
children, with the highest rate among children younger than 2 years of age (62.2 cases per 10,000 children)38. 
In the developing world, the annual incidence is higher and CAP is also more severe and is the largest killer of 
children39–41. Respiratory syncytial virus, HAdV and human metapneumovirus were more common among chil-
dren younger than 5 years of age than among older children38. Pediatric ARD, especially CAP, caused by HAdV 
infection has raised the public health concerns worldwide due to its high morbidity and mortality, especially in 
immunocompromised population. However, few large-scale epidemiologic and clinical data nationwide is cur-
rently available.
In our study, the HAdV infection rate was 5.09% in pediatric inpatients and outpatients in Southern China, 
whereas it was 12%–20.1% in hospitalized children in China42,43. The type distributions of HAdV in Southern 
and Northern China are completely different. In Southern China, most of HAdV-positive cases were caused by 
HAdV-3 (61.6%), followed by HAdV-7 (15.2%), which was similar with the previous study43. However, HAdV-7 
(46.2%) dominated in Northern China42. In Southern China, the peak season of HAdV infection rates was sum-
mer, with the exception of 2010. This was consistent with the study in hospitalized children in Southern China 
during 2012–201343, but it was different from Northern China (winter)42.
We also found emergent HAdV-14 and HAdV-21 and re-emergent HAdV-55 in Southern China, which may 
have potential to cause more outbreaks in this area, similar with ARD outbreaks in Northern China3,17,18,21,44. 
Region Product Position
Mutation in DNA Amino acid substitution
OP01 IP01 IP02 IP03 IP04 IP05 IP06 OP01 IP01 IP02 IP03 IP04 IP05 IP06
L1 Virus-associated RNA II 10815 — — — — — Insertion of T — — — — — — — —
L4 Hexon assembly- associated protein 24298 — — C → T C → T — — — — — A → A A → A — — —
E3 Non-coding region 29947 Insertion of T — — — — — — — — — — — —
E3 membrane protein E3 RID-alpha 29983 — G → A — — — — — — R → K — — — — —
30060 — G → A — — — — — — D → N — — — — —
30162 — G → A — — — — — — D → N — — — — —
30178 — G → A — — — — — — R → Q — — — — —
E4 34 kDa protein 33155 — — — G → T — — — — — — P → Q — — —
Table 6.  Comparative genomic analysis of the seven HAdV-7d isolates from this study. The reference 
genome is HAdV-7 strain 0901HZ/ShX/2009. Nucleic acid and amino acid sequence mutations are noted, 
along with their genome locations of the coding regions. “—”: no change or not applicable. Seven isolates 
are included: one from outpatient (OP) causing mild respiratory disease named OP01_2011, three from 
inpatients (IP; fatal outcome) named IP01_2010, IP02_2011 and IP03_2011, two from severe cases (required 
intensive care and mechanical ventilation) named IP04_2011 and IP05_2012, and one from comparatively mild 
respiratory disease (diagnosed with bronchitis and discharged after 4-day hospitalization) named IP06_2012.
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Remarkably, we found HAdV-14 emerged in September 2010, one month earlier than the first HAdV-14 strain 
reported in China21. The relationship between the two strains merits further investigation. Another study in 
Northern China found that HAdV-55 had higher pneumonia severity index scores in adolescent and adult 
patients compared with those with other types3. However, due to the difference both in case number of each type 
and in the age groups, the severity of illness caused by HAdV-7 and -55 cannot be compared between their study 
and ours.
Moreover, a high rate of HAdV co-infections (36.8%) with other respiratory viruses was also found. The dom-
inant pathogens co-infected with HAdV were RSV, HBoV, HPIV and HCoV, which was similar to a report from 
Northern China42. However, no statistically significant difference was found in terms of clinical manifestations 
and laboratory data between HAdV co-infection and HAdV single infection.
HAdV-7d was firstly identified in 1980 in Beijing and rapidly became the major genome type circulating in 
China through 199045. In 2009 and 2011, HAdV-7d re-emerged in China after an approximately 20-year absence 
and caused two ARD outbreaks in children with a fatality1,7. It was also the prevalent genome type in Japan dur-
ing 1987 to 199246 and in Korea during two outbreaks in 1995–1996 and 2001–200247, with a high fatality rate 
(18%) in children48. Recently, it emerged to cause adult severe CAP in the USA during 2013–201427,32. In our 
study, HAdV-7d caused more severe clinical manifestations and adverse consequences than other types, par-
ticularly HAdV-3 and HAdV-2 (61 and 12 cases, respectively), with longer duration of fever, higher morbidity of 
tachypnea/dyspnea, pleural effusion, diarrhea, hepatosplenomegaly, and consciousness alteration, as well as with 
higher rates of pneumonia, mechanical ventilation and death. As there were relatively few cases of HAdV-14 and 
HAdV-55 infection in our samples, whether HAdV-7d can cause more severe clinical manifestations or adverse 
consequences than these latter two types is unknown. More cases will be collected for further analysis.
In our study, whole-genome sequencing was carried out on Ion Torrent PGMTM using 318 v2 chips, which 
yielded 6,063,042 reads with an average length of approximately 182 bp as well as a mean coverage of 2,409x. Gaps 
and ambiguous sequences were PCR-amplified using different primers and re-sequenced by Sanger method for 
more than three-fold coverage. The genome ends were determined by direct end sequencing using genomic DNA 
as template. Given that Ion Torrent could not generate reads at long (> 14-base) homopolymer tracts, and cannot 
predict the correct number of bases in homopolymers > 8 bases long49, there may be a possibility of sequencing 
error in these regions. Additionally, the reported sequencing error rate for Ion Torrent was 1.78%. The number of 
error-free reads, without a single mismatch or indel, was 15.92%49.
We believe that genetic differences in the HAdV-7 genomes played an important role in clinical consequences 
of pediatric ARD with HAdV-7d causing more severe illness. Unexpectedly, we observed that the complete 
genome sequences of HAdV-7d isolates from mild, severe and fatal respiratory diseases were almost indistin-
guishable. Also surprisingly, strains IP04_2011 (severe case) and IP06_2012 (mild case) were 100% identical with 
each other as well as with the fatal strain (0901/HZ/ShX/2009) from the 2009 ARD outbreak7,15; the other five 
strains had only a few nucleotide mutations. To our knowledge, this is the first report that the complete genomes 
Figure 3. Determination of genome types of HAdV-7 isolates from children with ARD in Guangzhou, 
Southern China. The in silico restriction endonuclease analysis (REA) was performed using the Vector NTI 
11.5 (Invitrogen Corp; San Diego) to identify the genome types of circulating HAdV-7 isolates OP01_2011 
(lane O1; KP670857), IP01_2010 (lane I1; KP670858), IP02_2011 (lane I2; KP670856) and IP05_2012 (lane 
I5; KP670860) (A). Genome sequences of strains Gomen type 7 prototype Gomen (lane G; AY594255) and 
DG01_2011 7d (lane 7d; KC440171) were also analyzed with BamHI, BclI, BglI, BglII, BstEII, HindIII, HpaI, 
EcoRI, SalI, SmaI, XbaI, and XhoI (TaKaRa Corp.; China) respectively, as described earlier (Zhao et al. Sci 
Rep, 2014, 4; doi:10.1038/srep07365). The agarose gel electrophoresis of RE digested genomic DNA was also 
performed to confirm the in silico REA (B). IP01_2010 (lane I1; KP670858) and IP06 (lane I6; KP670859) 
were chosen to be analyzed. All the seven HAdV-7 isolates in this study have identical REA profiles with each 
other, different from the Gomen prototype, identified as genome type HAdV-7d. M, molecular weight markers 
corresponding to a 500 bp DNA Ladder (A) and DL10,000 DNA Marker (B) respectively. Nota bene: the agarose 
gel electrophoresis of RE digested genomic DNA was not run at the same time but under the same conditions.
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of three isolates from different periods were identical with each other, which confirms the expected degree of 
genomic sequence conservation and stability of HAdVs. Based on the genome sequence identity, we conclude that 
strains IP04_2011 and IP06_2012 in Guangzhou originated from strain 0901/HZ/ShX/2009 in Xixiang County, 
Shaanxi Province, although both cities are more than 1,000 kilometers apart. The unexpectedly high genome 
identities between isolates from mild, severe and fatal cases indicate that the difference in HAdV-7d pathogenicity 
may be due to host immunity. The detailed risk factors associated with adverse consequences caused by HAdV-7d 
merit further investigation.
Recombination analysis revealed that the genome variant 7d differs from the 1950s-era prototype strain by a 
lateral gene transfer, substituting the coding region for the L1 52/55 kDa DNA packaging protein from HAdV-161. 
Our phylogenetic analysis confirmed this recombination even in HAdV-7b, 7d, 7d2, and 7 h (Fig. 4D), while not 
in the prototype Gomen strain. The importance of this recombination remains unknown. However, a previous 
study found that this protein was expressed in both the early and late stages of infection50. L1 52/55 kDa proteins 
and IVa2 interacted in infected cells and bound in vivo to the packaging sequence50,51. It was an essential protein 
absolutely required for DNA packaging and encapsidation52, which contributed to the adenoviral reproduction. 
All the emergent pathogens (7b, 7d, 7d2, and 7h) contained this particular moderate sized recombination from 
HAdV-B16 into the HAdV-7 genome chassis. These data provide a clue that the L1 52/55 kDa DNA packaging 
protein may be associated with the HAdV-7 hypervirulent phenotype, but it requires confirmation.
Figure 4. Phylogenetic analysis of the HAdV-7 isolates associated with mild, severe and fatal respiratory 
diseases. Panels A, B, C, D and E represent the phylogenetic trees of hexon, penton genes, fiber, L1 52/55 kDa 
DNA packaging protein, and the whole genomes of HAdV-7, respectively. The neighbor-joining trees with 
1,000 replicates were constructed using the MEGA 6.06 software and by applying default parameters, with a 
maximum-composite-likelihood method. The HAdV-7d isolates with whole genomes sequenced in this study 
were highlighted with triangles, including the strains from fatal cases indicated in filled triangles. The archived 
HAdV-7 genome sequences, hexon, penton, fiber, and 52/55 kDa sequences with GenBank Accession Numbers, 
country of isolation, strain name, year of isolated (if available), and genome type (if available) were included in 
this phylogenetic analysis.
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In conclusion, this study identified the circulating HAdV types associated with pediatric ARD in Southern 
China along with clinical features and the whole-genome sequencing analysis. In Southern China, the predom-
inant types in children were HAdV-3 and HAdV-7. The peak season of HAdV infection in 2011–2012 was sum-
mer. The re-emergent HAdV-7d isolates originated from the earlier strain associated with a fatal ARD outbreak 
(2009). HAdV-7d caused more severe illness and higher fatality rate in pediatric inpatients than other types. 
The L1 52/55 kDa DNA packaging protein may be associated with the HAdV-7 hypervirulent phenotype. Fever, 
cough, and sore throat were the three most common respiratory symptoms of severe HAdV infections. The vac-
cine against HAdV-7 is in urgent need in both China and other population-dense countries. HAdV-7d associated 
with higher severity of illness has re-emerged in China and may have the potential to cause more outbreaks. 
Clinicians should pay particular attention to HAdVs in children with ARD. We call attention to urge extensive 
and continuous epidemiological surveillance and genetic characterization of the currently circulating HAdV 
strains in China, as well as in other countries with close-quartered and/or vulnerable populations.
Methods
Study design and clinical specimens. This study was carried out in the pediatric department of Zhujiang 
Hospital, Southern Medical University. The pediatric outpatient and inpatient cases under 14 years with influen-
za-like symptoms and clinically confirmed ARD from 2010 to 2012 were included in this study. Nasopharyngeal 
swab specimens from these patients were collected. All the experimental protocols in this study were approved by 
the Medical Ethics Board of Southern Medical University and were carried out in accordance with the approved 
guidelines. The informed consents for participation in this study were obtained from guardians of all the under-
aged participants. Data records of the samples, sample collection and analysis are de-identified and completely 
anonymous.
Microbiological diagnostic tests. Human adenovirus (HAdV), influenza virus A and B (Flu A & B), 
human parainfluenza virus (HPIV) types 1–4, respiratory syncytial virus (RSV), respiratory enteroviruses and 
rhinoviruses (RHV), human metapneumovirus (hMPV), human coronaviruses (HCoV) 229E, OC43, NL63 and 
HKU1, human bocavirus (HBoV) were detected from the specimens by real-time fluorescent PCR according to 
the methods described earlier53–56.
Virus culture, identification, and molecular typing of HAdVs. The nasopharyngeal swab specimens 
from HAdV-positive patients were inoculated into HEp-2 cells and cytopathic effect (CPE) was monitored for ten 
days. The HAdVs were molecular typed by PCR amplification and sequencing of all seven hypervariable regions 
in the hexon gene57. Molecular types were determined by BLASTN of the assembling contigs against existing 
GenBank sequences.
HAdV-7 whole-genome sequencing, annotation and phylogenetic analysis. Purified HAdV 
genomic DNA was submitted to Sagene Bio Co. (Guangzhou, China) for next generation whole-genome sequenc-
ing on Ion Torrent Personal Genome Machine (PGMTM). In brief, genomic libraries were prepared using the 
Ion Xpress plus fragment library kit (Life Technologies) and barcoded adapters were linked to DNA fragments, 
then amplified by emulsion PCR with Ion PGM 200 Xpress Template kit (Life Technologies). After breaking 
the emulsion, and adding the sequencing primer and polymerase, the completely prepared Ion Sphere Particle 
(ISP) beads of seven samples were loaded into Ion 318 v2 chips and individually sequenced on Ion Torrent PGM, 
with 500 flows generating 6,063,042 reads with an average length of 182 bp, and a mean coverage of 2,409x. 
All the sequencing ladders were assembled with the Program to Assemble Spliced Alignments (PASA) tool58 
and SEQMAN software from the Lasergene package (DNAStar; Madison, WI). HAdV-7 strain 0901HZ/ShX/
CHN/2009 (35239 bps) was chosen as the reference genome. The PASA assembly command line is as followed: 
“%../scripts/Launch_PASA_pipeline.pl -c alignAssembly.config -C -R -g genome_sample.fasta –t all_sample.
fasta.clean -T -u all_sample.fasta -f FL_acs.txt -ALIGNER blat gmap -CPU 2”. The configuration file was input 
after “-c”; “genome_sample.fasta” represented the reference genome file name. Because we used PASA to assemble 
virus genomes with a reference genome, “-t” and “-u” parameters followed the same fasta file of virus sequenc-
ing data, despite different file names. “-ALIGNER” parameter followed two alignment methods, blat and gmap. 
The other parameters were set as default. Two CPUs were used to run the program simultaneously. Gaps and 
ambiguous sequences were PCR-amplified using different primers and re-sequenced by Sanger method for more 
than three-fold coverage. Both 5′ - and 3′ -ends including inverted terminal repeats were sequenced directly using 
genomic DNA as template, as described earlier1. The genome sequences were annotated based on the previous 
annotation of HAdV-7 prototype strain (Gomen; 1952)59 and deposited into GenBank database. The Molecular 
Evolutionary Genetics Analysis (MEGA) version 6.06 software (http://www.megasoftware.net/megamac.php) 
was used for phylogenetic analyses of HAdV-7 hexon, fiber, penton genes, L1 52/55 kDa DNA packaging protein 
gene and the whole genomes, with additional sequences retrieved from GenBank database. Neighbor-joining 
phylogenetic trees with 1,000 boot-strap replicates were constructed using a maximum-composite-likelihood 
method with default parameters.
Genome type identification by in silico and agarose gel electrophoresis restriction endonuclease 
analysis (REA). Vector NTI Advance 11.5 (Invitrogen Corp.; San Diego, CA. USA) was used for the in silico 
REA analysis of the HAdV-7 whole-genome sequences, as described earlier1,60. Twelve restriction enzymes 
(BamHI, BclI, BglI, BglII, BstEII, EcoRI, HindIII, HpaI, SmaI, SalI, XbaI, and XhoI) (TaKaRa Corp.; China) were 
chosen according to the nomenclature system developed by Li and colleagues45. Genome types of HAdV-7 were 
determined by comparing both in silico and agarose gel electrophoresis REA profiles with other HAdV-7 genome 
types reported earlier1.
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Statistical analysis. Data statistical operations were performed by the SPSS program. Descriptive statistics 
was used for all variables; the continuous variables were summarized as medians and ranges, and the categorical 
variables were summarized as frequencies and proportions. Student’s t-test, Chi square test or Fisher exact test 
was used where appropriate, to determine the difference between groups.
GenBank accession numbers. The sequences used for phylogeny analyses are summarized in 
Supplementary Table S1, with GenBank accession number, country of isolation, strain name, year of isolated (if 
available), and genome type (if available) included.
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